SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Akanda to bring Cookies branded products to Portugal

    By
    Home / Akanda to bring Cookies branded products to Portugal

    Under the agreement, Akanda will cultivate, manufacture and sell Cookies branded products in Portugal, including operating Cookies branded pharmacy outlets.

    Akanda has stated that the multi-year agreement enables the company to pursue the current medical and future adult-use opportunities in Europe with one of the best-known cannabis brands and highest quality genetics in the world.

    Cookies is the brainchild of rapper and entrepreneur Berner (Gilbert Milam), who was recently featured on the cover of Forbes. The company currently has over 53 retail locations spanning five total countries including 12 states in the US, selling lifestyle apparel as well as recreational and medicinal cannabis products as regulations allow.

    Read more: Cookies launches flagship store in Austria with InterCure

    Akanda intends to initially produce EU GMP certified Cookies branded high THC medical cannabis products at its flagship indoor premium cultivation and manufacturing facility in Sintra, Portugal. The agrreement also enables Akanda to offer Cookies’ non-cannabis merchandise.

    Additionally, Akanda is able to exclusively open and operate flagship Cookies branded pharmacy outlets throughout the country.

    Read more: Cookies CEO to become first cannabis executive to feature on Forbes front cover

    Akanda’s CEO, Tej Virk, commented: “Adding the iconic Cookies brand and their high THC strains to Akanda’s platform is an important catalyst in our quest to lead the cannabis industry in Europe. 

    “Cookies premium genetics are an essential pillar to have in our portfolio as these markets begin to open up. We can’t wait to introduce the brand to consumers in Portugal, and strains to patients throughout Europe.”

    Co-founder and CEO of Cookies, Berner, commented: “The fact that Portugal decriminalised drugs back in the early 2000’s and people in the US are still being locked up for cannabis 20 years later, shows the world, especially the US, that we can learn a lot from their forward thinking. 

    “The partners we chose in Portugal have one of the most advanced facilities I’ve seen and will be producing some of the best cannabis in the world. 

    “It’s partnerships like this that keep me excited about the growth and expansion of Cookies worldwide.”

    Virk continued: “The Cookies license agreement is enabled by our May 2022 acquisition of Portugal-based Holigen, which makes Akanda a cultivator, manufacturer and distributor of EU GMP certified medical cannabis with a state-of-the-art 20,000 square foot indoor cultivation site in Sintra dedicated to the cultivation of high THC premium cannabis as well as a large seven million square foot (180+ acres) outdoor facility located two hours south in Aljustrel.

    “It is further evidence that Akanda has secured one of the most prized cannabis assets in Europe. With brands and strains like Cookies, I’ve never been more confident about Akanda’s promising future.”

    [activecampaign form=31]

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free